… In CKD, expression of miRNA-486 (targets FoxO1 and PTEN), miRNA-26a (targets FoxO1 …
-based therapeutics for the treatment of muscle wasting in CKD and other catabolic conditions. …

… muscle is important for identifying new therapeutic targets and identifying novel approaches
to attenuate the muscle wasting … that treatment with either compound increased muscle …

… So far, not many treatment options to fight the muscle loss … in the skeletal muscle of both
muscle wasting disorders. In … ) is a selective target associated with a wasting state compared to …

… Although the treatment of muscle wasting due to starvation … The ubiquitin-proteasome
pathway as a therapeutic target for muscle wasting. J Support Oncol 2005; 3: 209-17. [144] Kwak …

… potential for treating various types of muscle wasting, especially cancer cachexia. … To
examine whether ActRIIB pathway blockade is also effective in reversing muscle wasting induced …

… of muscle atrophy have revealed potential targets for … with muscle wasting and cachexia
[46] . Consequently, genetic interference of the NFkB signaling attenuates muscle wasting [47] . …

… We will discuss how physical exercise or nutritional support can counteract muscle wasting,
… myoblasts [217], thus supporting the use of vitamin D to treat muscle wasting in cachexia. …

… cancer cachexia and muscle wasting, though … treatment with a specific antibody in vivo and
in vitro, and (4) the level in circulation increases in clinical situations inducing muscle wasting…

… ameliorated muscle wasting and improved muscle strength in vivo … targets to improve muscle
health and function in CKD. … and TA muscles over the same muscles of vehicle-treated CKD …

… Diagram shows targets of interventions to alleviate catabolic processes of … An interesting
approach yet to be tested for treatment of muscle wasting was recently shown to be effective in …